HER2 as a potential therapeutic target on quiescent prostate cancer cells-Reference-Cited by-同舟云学术

HER2 as a potential therapeutic target on quiescent prostate cancer cells

Published:2023-05 Issue: Volume:31 Page:101642
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Yumoto Kenji,Rashid Jibraan^ORCID,Ibrahim Kristina G.,Zielske Steven P.^ORCID,Wang Yu,Omi Maiko^ORCID,Decker Ann M.^ORCID,Jung Younghun,Sun Dan^ORCID,Remmer Henriette A.,Mishina Yuji,Buttitta Laura A.^ORCID,Taichman Russell S.,Cackowski Frank C.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Epidemiology and End Results Program (SEER) Cancer Stat Facts: Prostate Cancer,2022

2. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer;Revelos;In Vivo,2005

3. Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways;Chery;Oncotarget,2014

4. Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response;Horning;Cancer Res.,2018

5. Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone;Owen;EMBO Rep.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone niches in the regulation of tumour cell dormancy;Journal of Bone Oncology;2024-08

2. TransGEM: a molecule generation model based on Transformer with gene expression data;Bioinformatics;2024-04-17

3. Prostate Cancer and the Mevalonate Pathway;International Journal of Molecular Sciences;2024-02-10

4. Efficient Convolution Network to Assist Breast Cancer Diagnosis and Target Therapy;Cancers;2023-08-06